Equities research analysts at StockNews.com initiated coverage on shares of InspireMD (NYSE:NSPR – Get Free Report) in a note issued to investors on Monday. The firm set a “sell” rating on the stock.
InspireMD Stock Down 16.9 %
Shares of NSPR opened at $2.76 on Monday. InspireMD has a fifty-two week low of $1.81 and a fifty-two week high of $3.85. The firm’s 50 day moving average price is $2.58 and its 200 day moving average price is $2.51. The company has a market cap of $68.81 million, a P/E ratio of -3.63 and a beta of 0.96.
InspireMD (NYSE:NSPR – Get Free Report) last announced its earnings results on Tuesday, May 14th. The company reported ($0.21) earnings per share for the quarter, missing the consensus estimate of ($0.15) by ($0.06). InspireMD had a negative return on equity of 55.12% and a negative net margin of 350.35%. The business had revenue of $1.51 million for the quarter, compared to analysts’ expectations of $1.38 million. During the same period in the previous year, the company earned ($0.53) earnings per share. Research analysts forecast that InspireMD will post -0.82 earnings per share for the current year.
Institutional Inflows and Outflows
About InspireMD
InspireMD, Inc, a medical device company, focuses on the development and commercialization of MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Stent System, a mesh-covered self-expanding carotid stent; and SwitchGuard NPS, a non-invasive transcarotid artery revascularization device; as well as treating acute stroke with tandem lesions.
Featured Stories
- Five stocks we like better than InspireMD
- How to Capture the Benefits of Dividend Increases
- AbbVie Analysts Lead the Stock Higher as Humira Worries Recede
- Options Trading – Understanding Strike Price
- Harley-Davidson Stock Revs Up With Billion Dollar Buyback Program
- Market Cap Calculator: How to Calculate Market Cap
- Cruise Line Stock Sinks Despite Beating EPS and Raised Guidance
Receive News & Ratings for InspireMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InspireMD and related companies with MarketBeat.com's FREE daily email newsletter.